Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
VISEN Pharmaceuticals ( (HK:2561) ) just unveiled an update.
VISEN Pharmaceuticals has announced its Annual General Meeting scheduled for June 27, 2025, in Shanghai, China. Key agenda items include the re-election of several directors, reappointment of Ernst & Young as auditors, and granting directors the authority to repurchase shares and issue additional shares. These resolutions aim to enhance corporate governance and provide flexibility in capital management, potentially impacting the company’s operational strategies and shareholder value.
More about VISEN Pharmaceuticals
VISEN Pharmaceuticals is a company incorporated in the Cayman Islands, operating within the pharmaceutical industry. The company focuses on developing and providing pharmaceutical products and services, with a market presence indicated by its listing on the Hong Kong Stock Exchange.
YTD Price Performance: -36.34%
Average Trading Volume: 341,572
For an in-depth examination of 2561 stock, go to TipRanks’ Stock Analysis page.